Bulletin
Investor Alert

Arena Pharmaceuticals Inc.

NAS: ARNA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200715023/composite

$

44.54

Change

0.00 0.00%

Volume

Volume 23,497

Mar 27, 2020, 4:42 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200715023/composite

Previous close

$ 43.00

$ 44.54

Change

+1.54 +3.58%

Day low

Day high

$41.25

$45.80

Open
Open: 41.52

52 week low

52 week high

$32.95

$64.48

Open

Market cap

$2.24B

Average volume

654,812

P/E ratio

5.83

Rev. per Employee

$92,629

EPS

7.64

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/arna

MarketWatch News on ARNA

  1. Arena Pharmaceuticals upgraded to overweight from neutral at J.P. Morgan

    8:54 a.m. Jan. 31, 2020

    - Tomi Kilgore

  2. Arena Pharmaceuticals started at neutral with $51 stock price target at BofA Merrill Lynch

    10:39 a.m. Nov. 13, 2019

    - Tomi Kilgore

  3. Arena Pharmaceuticals shares tick lower on secondary offering

    4:22 p.m. March 20, 2018

    - Wallace Witkowski

  4. Charting the Market

    11:42 a.m. Aug. 25, 2017

    - Barron's Online

  5. Arena Pharma shares retreat slightly on secondary share offering

    4:31 p.m. July 11, 2017

    - Wallace Witkowski

  6. Arena Pharma Soars On Lung Disease Drug Study Results

    10:42 a.m. July 11, 2017

    - Barrons Blogs

  7. Arena Pharmaceuticals stock price target raised to $53 from $47 at Leerink

    8:11 a.m. July 11, 2017

    - Tomi Kilgore

  8. Arena Pharmaceuticals jumps 30% after positive drug study

    4:12 p.m. July 10, 2017

    - MarketWatch

  9. Arena Pharmaceuticals started at outperform with $5 stock price target at Leerink

    7:40 a.m. May 19, 2017

    - Tomi Kilgore

  10. Arena Pharmaceuticals started at outperform with $6 stock price target at FBR & Co.

    9:54 a.m. Sept. 15, 2016

    - Tomi Kilgore

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/arna

Other News on ARNA

  1. 6 Cheap Health Care Stocks

    11:30 a.m. March 9, 2020

    - GuruFocus.com

  2. NLS Pharmaceutics Seeks $40 Million U.S. IPO

    3:58 p.m. March 6, 2020

    - Seeking Alpha

  3. Psychedelic Medicine Stocks Capture The Attention Of Investors

    12:18 p.m. March 6, 2020

    - Seeking Alpha

  4. Arena Pharmaceuticals (ARNA) Investor Presentation - Slideshow

    11:48 a.m. Feb. 28, 2020

    - Seeking Alpha

  5. 10-K: ARENA PHARMACEUTICALS INC

    4:36 p.m. Feb. 27, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Notable earnings after Wednesday's close

    5:35 p.m. Feb. 25, 2020

    - Seeking Alpha

  7. Arena Pharmaceuticals Q4 2019 Earnings Preview

    5:35 p.m. Feb. 25, 2020

    - Seeking Alpha

  8. FDA requests removal of weight loss med Belviq

    3:29 p.m. Feb. 13, 2020

    - Seeking Alpha

  9. 6 New Credit Suisse Top Number-One Stock Picks for 2020

    12:09 p.m. Jan. 23, 2020

    - 247WallSt.com

  10. Arena Pharma's APD418 Fast Track'd in U.S. for heart failure

    9:12 a.m. Jan. 16, 2020

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/arna

Press Releases on ARNA

  1. Obesity Treatment Market is expected to see growth rate of 17.2%

    9:00 a.m. March 25, 2020

    - HTF Market Intelligence

  2. Equillium Strengthens Leadership Team with Key Appointments

    4:14 p.m. Feb. 27, 2020

    - GlobeNewswire

  3. Arena Pharmaceuticals to Present at the Upcoming Investor Conferences

    8:30 a.m. Feb. 20, 2020

    - PR Newswire - PRF

  4. ScienceMedia SUCCESSFULLY closes Series B financing round

    8:00 a.m. Feb. 18, 2020

    - PR Newswire - PRF

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.